Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022757
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-08-17
Brief Title:
Study of XNW5004 Tablet in Combination With KEYTRUDA Pembrolizumab in Subjects With Advanced Solid Tumors Who Failed Standard Treatments KEYNOTE F19
Sponsor:
Organization:
Evopoint Biosciences Inc